Connect & Inspire
Share Your Story
Explore & Discover
Treatment & Care
Press Room
Subscribe
LATEST POSTS
OSI’s SCIENTS Committee: Advancing Bench-to-Bedside Research
The Scientific Correlates and Innovative, Emerging New Technologies (SCIENTS) team explores new treatment options for osteosarcoma patients.
The Cancer Journey: What Patients and Caregivers Should Know
A Child Life Specialist shares what to expect following a diagnosis of osteosarcoma.
The Wampler Family’s Partnership with OSI Supports Innovative Research Study
Jennifer and John Wampler help fund emerging osteosarcoma research led by oncologist, Dr. Brian Crompton.
Connect & Inspire
Stories of inspiration, community, and survival
A Mom Continues Her Daughter’s Fight Against Cancer
After Vicki Bunke lost her 14-year-old daughter, Grace, to osteosarcoma, she started swimming across America to honor her legacy.
An Osteosarcoma Diagnosis Benched This Teen Athlete — But Not for Long
Two surgeries, six rounds of chemo and countless nights in the hospital couldn’t stop Cheyenne from being a source of inspiration for those around her.
Osteosarcoma of the Jaw Survivor Savors the Simple, Small Things in Life
Diagnosed with a very rare type of bone cancer when her second daughter was a newborn, Nicole gained new perspective and appreciation for life.
Share Your Story
Fill out the form below to tell us about yourself. Sharing stories of osteosarcoma families helps us raise awareness and funds for much-needed research.
Gavin, Osteosarcoma Patient
Explore & Discover
Stories of research, progress and exploration
Osteosarcoma Discovered in a 77-Million-Year-Old Dinosaur Bone
New research has led to the first diagnosis of advanced bone cancer in a dinosaur.
Meet Andrea Hayes, MD, OSI’s Strategic Advisory Board Member and Howard University’s First Female Chair of Surgery
This world-renowned pediatric surgical oncologist is determined to change osteosarcoma outcomes.
OSI’s SIFT Committee: Facilitating Groundbreaking Research
The Strategic Initiatives Funding Team fosters an environment of collaboration and innovation by seeking researchers who can transform how we treat osteosarcoma.
Treatment and Care
OSI Connect: Connecting Experts with Osteosarcoma Patients and Their Families Around the World
The free, virtual platform provides access to expert physicians in the field of osteosarcoma who serve as reliable resources and support during a patient’s greatest time of need.
A Paradigm Shift That May Change the Way Osteosarcoma is Treated
Pediatric oncologist and researcher, Richard Gorlick, MD, is on a mission to improve osteosarcoma outcomes.
OSI’s Director Unveils 2021’s Grant Recipients
After receiving a record 26 proposals, Lee Helman, MD, shares the three winning projects the institute is funding in its quest improve treatment and, ultimately, eradicate osteosarcoma.
Press Room
OSI News & updates
A Phase II clinical trial funded by The Osteosarcoma Institute is now enrolling
This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment.
Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates
Novel approach paves the way for vast expansion in the number of drugs targeting osteosarcoma
The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma
The Osteosarcoma Institute (OSI) announced today that it has awarded a grant to Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for a Phase II single arm study of olaparib (an FDA-approved PARP inhibitor) and ceralacertib/AZD6738 (an investigational ATR kinase inhibitor) in ...